Dealmaking in the fourth quarter of 2025 shows no signs of abating, with at least two announced “mega” M&A deals valued at more than $10 billion in the past week and at least a dozen deals valued at more than $1 billion. As deal activity continues to stay robust, sponsors and prospective acquirers are in a position to check for strong targets, particularly in the health care industry, where private equity interest continues to grow. According to polling numbers provided to Law.com from the Healthcare Private Equity Conference in New York last week, the largest concerns for PE investors in health care were macroeconomic factors (45%), followed by competition for transactions (26%), AI influencing transactions (19%) and the impact of private credit dry powder (10%).
Read the full article: Deal Watch: What Dealmakers Expect in Health Care PE Activity //
Source: https://www.law.com/americanlawyer/2025/10/21/deal-watch-what-dealmakers-expect-in-healthcare-pe-activity-/